Clinical Trials Directory

Trials / Completed

CompletedNCT02339272

Study of Synapsis and Recombination in Male Meiosis and the Implications in Infertility

Status
Completed
Phase
Study type
Observational
Enrollment
50 (actual)
Sponsor
Igenomix · Industry
Sex
Male
Age
Healthy volunteers
Not accepted

Summary

The aim of this study was to assess meiotic recombination in primary spermatocytes, synaptonemal complex length and the correlation with chromosomal abnormalities in testicular spermatozoa from infertile men with idiopathic non-obstructive azoospermia (NOA).

Detailed description

During the first meiotic division in spermatogenesis there are two critical events. First, synapsis between homologous chromosomes and formation of the synaptonemal complex (SC), which regulates sister chromatid cohesion and provides the template for localization of recombination machinery proteins. Secondly, recombination between homologous chromosomes, which is essential for the correct segregation. Errors during these two processes may induce incorrect segregation of chromosomes and are a major cause of gamete aneuploidy. The aim of this study was to assess meiotic recombination in primary spermatocytes, synaptonemal complex length and the correlation with chromosomal abnormalities in testicular spermatozoa from infertile men with idiopathic non-obstructive azoospermia (NOA). Prospective cohort study to assess meiotic progression, total length of SC, frequency of recombination and sperm aneuploidy in samples obtained from testicular biopsies from NOA patients. The study group was compared with a control group from post-vasectomized (OA) patients. Immunocytogenetics with SCYP3, CREST and MLH1 antibodies for meiotic progression, SC length, and recombination. Fluorescence in situ Hybridization (FISH) for chromosomes 1, 4, 6, 13, 16, 18, 21, 22 in primary spermatocytes and chromosomes 13, 18, 21, X, Y on sperm. MicroMeasure 3.3 program was used for SC length.

Conditions

Interventions

TypeNameDescription
OTHERnon interventional

Timeline

Start date
2008-01-01
Primary completion
2014-12-01
Completion
2015-01-01
First posted
2015-01-15
Last updated
2015-01-15

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT02339272. Inclusion in this directory is not an endorsement.